Back

Elevated levels of BNP and fibroblast growth factor 23 in patients with atrial fibrillation : an analysis of 40 cardiovascular biomarkers in 667 unselected hospitalized patients.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Biomarkers - Heart Failure Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Yanish Purmah

Sandwell and West Birmingham Hospitals NHS Trust, Birmingham (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Plasma trimethylamine-N-oxide is associated with atrial fibrillation
Doctor G. Svingen (Bergen, NO)
Abstract
Presentation thumbnail
NT-proBNP is a more sensitive and specific biomarker for the prediction of future atrial fibrillation than for forthcoming onset of heart failure: results from the observational DIAST-CHF study
Miss S. Werhahn (Berlin, DE)
Abstract
Presentation thumbnail
Circulating lipopolysaccharides and risk of major adverse cardiovascular events in atrial fibrillation: association with mediterranean diet adherence
Associate Professor D. Pastori (Rome, IT)
Abstract Slides
Presentation thumbnail
Effect of rivaroxaban on coagulation and inflammation biomarkers: results from an X-VeRT substudy
Doctor Y. Purmah (Birmingham, GB)
Abstract
Presentation thumbnail
Preferential association of biomarkers with post-ablation recurrence in non-paroxysmal atrial fibrillation indicates the role of inflammation in persistence of the arrhythmia
Doctor S. Mohanty (Austin, US)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Biomarkers - Heart Failure

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources